Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAIT cells exacerbate colonic inflammation in a genetically diverse murine model of spontaneous colitis.

Mucosal immunology·2025
Same author

ATM-deficient murine thymic T-cell lymphoblastic lymphomas are PTEN-deficient and require AKT signaling for survival.

PloS one·2024
Same author

Lessons From COVID-19 Testing Research: The Power of Rapid Response.

American journal of public health·2024
Same author

The All of Us Research Program is an opportunity to enhance the diversity of US biomedical research.

Nature medicine·2024
Same author

MAIT cells drive chronic inflammation in a genetically diverse murine model of spontaneous colitis.

bioRxiv : the preprint server for biology·2023
Same author

TRAF6 and TRAF2/3 Binding Motifs in CD40 Differentially Regulate B Cell Function in T-Dependent Antibody Responses and Dendritic Cell Function in Experimental Autoimmune Encephalomyelitis.

Journal of immunology (Baltimore, Md. : 1950)·2023
Same journal

A human-specific genetic modifier reconfigures large-scale cortical network dynamics underlying behavioral performance.

bioRxiv : the preprint server for biology·2026
Same journal

<i>Staphylococcus aureus</i> uses a eukaryotic-like uridyltransferase to make UDP-GlcNAc for cell wall synthesis.

bioRxiv : the preprint server for biology·2026
Same journal

Dynamic redistribution of eIF4F controls cap-dependent translation initiation.

bioRxiv : the preprint server for biology·2026
Same journal

When does additional information improve accuracy of RNA secondary structure prediction?

bioRxiv : the preprint server for biology·2026
Same journal

Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Noradrenergic infraslow rhythm during sleep is the critical link between heart-rate dynamics and memory consolidation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.5K

Tumor suppressor p53 controls thymic NKT17 development.

Sofia Celli, Masashi Watanabe, Richard J Hodes

    Biorxiv : the Preprint Server for Biology
    |October 7, 2024
    PubMed
    Summary
    This summary is machine-generated.

    The tumor suppressor p53 specifically controls thymic invariant natural killer T-17 (iNKT17) cell development. Loss of p53 increases iNKT17 cells, which show heightened DNA damage responses, suggesting a role in genomic stability.

    More Related Videos

    Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
    17:59

    Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

    Published on: April 3, 2011

    12.3K
    Examination of Thymic Positive and Negative Selection by Flow Cytometry
    14:29

    Examination of Thymic Positive and Negative Selection by Flow Cytometry

    Published on: October 8, 2012

    21.8K

    Related Experiment Videos

    Last Updated: Jun 11, 2025

    Yeast As a Chassis for Developing Functional Assays to Study Human P53
    14:57

    Yeast As a Chassis for Developing Functional Assays to Study Human P53

    Published on: August 4, 2019

    9.5K
    Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
    17:59

    Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

    Published on: April 3, 2011

    12.3K
    Examination of Thymic Positive and Negative Selection by Flow Cytometry
    14:29

    Examination of Thymic Positive and Negative Selection by Flow Cytometry

    Published on: October 8, 2012

    21.8K

    Area of Science:

    • Immunology
    • Cell Biology
    • Cancer Biology

    Background:

    • The tumor suppressor p53 is known to inhibit tumorigenesis.
    • Its precise role in T cell biology, including thymic T cell development, remains incompletely understood.
    • Invariant natural killer T (iNKT) cells are innate-like T cells developing in the thymus, comprising NKT1, NKT2, and NKT17 subsets.

    Purpose of the Study:

    • To investigate the role of the tumor suppressor p53 in the development of different invariant natural killer T (iNKT) cell subsets.
    • To determine if p53 expression is specific to certain iNKT cell populations.
    • To explore the relationship between p53, DNA damage, and iNKT17 cell development.

    Main Methods:

    • Analysis of p53 expression levels in different thymic T cell populations.
    • Comparative analysis of iNKT cell subset development in wild-type versus p53-deficient mice.
    • Assessment of cytokine production and DNA damage markers (γH2AX) in iNKT cell subsets.

    Main Results:

    • p53 is highly expressed in thymic NKT17 cells compared to other T cell populations.
    • Loss of p53 in T cells selectively increased the number of thymic NKT17 cells without affecting NKT1, NKT2, or conventional T cells.
    • NKT17 cells exhibited higher basal γH2AX expression, indicative of DNA damage, which was further elevated in p53-deficient NKT17 cells.

    Conclusions:

    • The tumor suppressor p53 plays a specific regulatory role in thymic NKT17 cell development.
    • Absence of p53 leads to an expansion of NKT17 cells, associated with increased DNA damage response.
    • These findings suggest p53 acts to control genomic instability within the NKT17 cell lineage during thymic development.